UBS Starts Biohaven Pharmaceutical Holding (BHVN) at Buy

March 10, 2021 8:02 PM EST
Get Alerts BHVN Hot Sheet
Price: $105.02 +1.51%

Rating Summary:
    11 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 12 | Down: 7 | New: 31
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

UBS initiates coverage on Biohaven Pharmaceutical Holding (NYSE: BHVN) with a Buy rating and a price target of $108.00.

For an analyst ratings summary and ratings history on Biohaven Pharmaceutical Holding click here. For more ratings news on Biohaven Pharmaceutical Holding click here.

Shares of Biohaven Pharmaceutical Holding closed at $80.64 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

UBS